OnCore Fees

A standard fee is assessed for all studies that require registration in OnCore-CTMS (Clinical Trial Management System)*.

This is a line-item direct cost that should be incorporated into study budgets. This is part of a larger effort to better manage the financial performance of clinical trials. OnCore-CTMS Fees are assessed at study start-up (site initiation visit) and annually, thereafter. 

OnCore assesses their fees to the University of Utah based on the use of the system, not the size of the budget or type of study. 

Study teams will receive an invoice from the Clinical Research Support Office at IRB Approval and annually, thereafter for the life of the study for OnCore-CTMS fees. 

• OnCore-CTMS Fees are in effect now for all new studies that were added to OnCore as of 5/1/22.
• Studies that were underway and had a fully executed budget and contract prior to 5/1/22 will not be assessed OnCore-CTMS fees.
• No OnCore-CTMS Fees for start-up/annual fees will be assessed if using OnCore for participant payments only. See our Participant Payments page for more information. 

The exact OnCore-CTMS Fees can be found in the Clinical Research Institutional Fee Schedule-(UU SOP 13). These fees include a one-time start-up fee and annual maintenance fees throughout the life of the study and include F&A/overhead. The OnCore-CTMS Fee represents a fee-for-service provided by the CTSI, Clinical Research Support Office for use of the OnCore-CTMS. These fees are non-negotiable.

For federally funded or foundation studies, these OnCore-CTMS Fees are charged directly to the college or institute that is receiving F&A Funds from the grant/contract.  They are not charged to the department or study budget.

A formal waiver process for OnCore-CTMS Fees is available by submitting a ticket to Service Now Support.  For additional questions regarding the financial implications of the OnCore-CTMS Fees, including startup and annual fees, please submit a Service Now ticket for assistance.

*Please see our About OnCore page for which studies are required to be registered in OnCore.